DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name ▲ | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0028860 | Oculocerebrorenal Syndrome | INPP5D | 3635 | inositol polyphosphate-5-phosphatase D | Q92835 |
C0028860 | Oculocerebrorenal Syndrome | ARSH | 347527 | arylsulfatase family member H | Q5FYA8 |
C0028860 | Oculocerebrorenal Syndrome | INPP5K | 51763 | inositol polyphosphate-5-phosphatase K | Q9BT40 |
C0028860 | Oculocerebrorenal Syndrome | INPP5A | 3632 | inositol polyphosphate-5-phosphatase A | Q14642 |
C0028860 | Oculocerebrorenal Syndrome | MTM1 | 4534 | myotubularin 1 | Q13496 |
C0028860 | Oculocerebrorenal Syndrome | OCRL | 4952 | OCRL inositol polyphosphate-5-phosphatase | Q01968 |
C0028860 | Oculocerebrorenal Syndrome | PAFAH1B1 | 5048 | platelet activating factor acetylhydrolase 1b regulatory subunit 1 | P43034 |
C0028860 | Oculocerebrorenal Syndrome | PTEN | 5728 | phosphatase and tensin homolog | P60484 |
C0268494 | Oculocutaneous albinism type 1 | CALR | 811 | calreticulin | P27797 |
C0268494 | Oculocutaneous albinism type 1 | CANX | 821 | calnexin | P27824 |
C4551504 | Oculocutaneous albinism type 1A | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C0028866 | Oculomotor Nerve Paralysis | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
C0796059 | Oculopalatoskeletal syndrome | MASP1 | 5648 | mannan binding lectin serine peptidase 1 | P48740 |
C0796059 | Oculopalatoskeletal syndrome | COLEC11 | 78989 | collectin subfamily member 11 | Q9BWP8 |
C0271270 | Oculovestibuloauditory syndrome | PIGW | 284098 | phosphatidylinositol glycan anchor biosynthesis class W | Q7Z7B1 |
C0271270 | Oculovestibuloauditory syndrome | PIGV | 55650 | phosphatidylinositol glycan anchor biosynthesis class V | Q9NUD9 |
C0271270 | Oculovestibuloauditory syndrome | GPAA1 | 8733 | glycosylphosphatidylinositol anchor attachment 1 | O43292 |
C0271270 | Oculovestibuloauditory syndrome | PIGO | 84720 | phosphatidylinositol glycan anchor biosynthesis class O | Q8TEQ8 |
C0271270 | Oculovestibuloauditory syndrome | GBA | 2629 | glucosylceramidase beta | P04062 |
C0271270 | Oculovestibuloauditory syndrome | DLAT | 1737 | dihydrolipoamide S-acetyltransferase | P10515 |
C0271270 | Oculovestibuloauditory syndrome | INPP5E | 56623 | inositol polyphosphate-5-phosphatase E | Q9NRR6 |
C0271270 | Oculovestibuloauditory syndrome | PGAP3 | 93210 | post-GPI attachment to proteins phospholipase 3 | Q96FM1 |
C0271270 | Oculovestibuloauditory syndrome | NGLY1 | 55768 | N-glycanase 1 | Q96IV0 |
C0271270 | Oculovestibuloauditory syndrome | PIGL | 9487 | phosphatidylinositol glycan anchor biosynthesis class L | Q9Y2B2 |
C0271270 | Oculovestibuloauditory syndrome | PIGY | 84992 | phosphatidylinositol glycan anchor biosynthesis class Y | Q3MUY2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024